These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial. Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310 [TBL] [Abstract][Full Text] [Related]
4. Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin. Elwood RL; Spencer SE Ann Pharmacother; 2006 Feb; 40(2):347-50. PubMed ID: 16449537 [TBL] [Abstract][Full Text] [Related]
5. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia. Onder AM; Chandar J; Simon N; Diaz R; Nwobi O; Abitbol CL; Zilleruelo G Nephrol Dial Transplant; 2008 Aug; 23(8):2604-10. PubMed ID: 18332071 [TBL] [Abstract][Full Text] [Related]
6. [Value of an antibiotic lock for the prevention of bacteremia recurrence from central catheters in chronic hemodialysis]. Fourcade J; Mallaval FO; Raffenot D; Mercier D; Maret J; Morel B Nephrologie; 2001; 22(8):457-8. PubMed ID: 11811009 [TBL] [Abstract][Full Text] [Related]
7. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Bleyer AJ Clin J Am Soc Nephrol; 2007 Sep; 2(5):1073-8. PubMed ID: 17702738 [TBL] [Abstract][Full Text] [Related]
8. Barriers to antibiotic lock therapy in children with intravascular catheter-related bloodstream infections. Robinson JL; Tawfik G; Roth A Pediatr Infect Dis J; 2005 Oct; 24(10):944. PubMed ID: 16220107 [No Abstract] [Full Text] [Related]
9. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468 [TBL] [Abstract][Full Text] [Related]
10. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. Droste JC; Jeraj HA; MacDonald A; Farrington K J Antimicrob Chemother; 2003 Apr; 51(4):849-55. PubMed ID: 12654743 [TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Carratalà J; Niubó J; Fernández-Sevilla A; Juvé E; Castellsagué X; Berlanga J; Liñares J; Gudiol F Antimicrob Agents Chemother; 1999 Sep; 43(9):2200-4. PubMed ID: 10471564 [TBL] [Abstract][Full Text] [Related]
12. [Management of central venous catheter: prevention of thrombosis and bacteremia]. Lomonte C; Basile C G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966 [TBL] [Abstract][Full Text] [Related]
13. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. Campos RP; do Nascimento MM; Chula DC; Riella MC J Am Soc Nephrol; 2011 Oct; 22(10):1939-45. PubMed ID: 21852579 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. De Sio L; Jenkner A; Milano GM; Ilari I; Fidani P; Castellano A; Gareri R; Donfrancesco A Pediatr Infect Dis J; 2004 Oct; 23(10):963-5. PubMed ID: 15602201 [TBL] [Abstract][Full Text] [Related]
15. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Nori US; Manoharan A; Yee J; Besarab A Am J Kidney Dis; 2006 Oct; 48(4):596-605. PubMed ID: 16997056 [TBL] [Abstract][Full Text] [Related]
16. Recommendations and reports about central venous catheter-related infection. Bacuzzi A; Cecchin A; Del Bosco A; Cantone G; Cuffari S Surg Infect (Larchmt); 2006; 7 Suppl 2():S65-7. PubMed ID: 16895510 [TBL] [Abstract][Full Text] [Related]
18. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356 [TBL] [Abstract][Full Text] [Related]
19. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Bookstaver PB; Williamson JC; Tucker BK; Raad II; Sherertz RJ Ann Pharmacother; 2009 Feb; 43(2):210-9. PubMed ID: 19193593 [TBL] [Abstract][Full Text] [Related]